Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells-Reference-Cited by-同舟云学术

Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells

Published:2017-03-07 Issue:12 Volume:114 Page:E2337-E2346
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proc Natl Acad Sci USA

Author:

Bierie Brian,Pierce Sarah E.,Kroeger Cornelia,Stover Daniel G.,Pattabiraman Diwakar R.,Thiru Prathapan,Liu Donaher Joana,Reinhardt Ferenc,Chaffer Christine L.,Keckesova Zuzana,Weinberg Robert A.

Funder

DOD | Congressionally Directed Medical Research Programs (CDMRP)

HHS | NIH | National Cancer Institute (NCI)

Department of Health, Australian Government | National Health and Medical Research Council (NHMRC)

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference48 articles.

1. EMT: 2016

2. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

3. Fibroblasts in cancer

4. Prospective identification of tumorigenic breast cancer cells

5. Tackling the cancer stem cells — what challenges do they pose?

Cited by 279 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential of Epigallocatechin Gallate in Targeting Cancer Stem Cells: A Comprehensive Review;Current Medicinal Chemistry;2024-10

2. Human Umbilical Cord Mesenchymal Stem Cell Exosome-derived miR-335-5p Alleviated Lipopolysaccharide-induced Acute Lung Injury by Regulating the m6A Level of ITGβ4 Gene;Current Medicinal Chemistry;2024-10

3. ALDH1A3 is the switch that determines the balance of ALDH+ and CD24−CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer;Oncogene;2024-09-09

4. Multi-omic lineage tracing predicts the transcriptional, epigenetic and genetic determinants of cancer evolution;Nature Communications;2024-09-01

5. Enhanced desmosome assembly driven by acquired high-level desmoglein-2 promotes phenotypic plasticity and endocrine resistance in ER+ breast cancer;Cancer Letters;2024-09